JP2023537369A5 - - Google Patents

Info

Publication number
JP2023537369A5
JP2023537369A5 JP2023508084A JP2023508084A JP2023537369A5 JP 2023537369 A5 JP2023537369 A5 JP 2023537369A5 JP 2023508084 A JP2023508084 A JP 2023508084A JP 2023508084 A JP2023508084 A JP 2023508084A JP 2023537369 A5 JP2023537369 A5 JP 2023537369A5
Authority
JP
Japan
Prior art keywords
approximately
combination pharmaceutical
nsaid
ketotifen
pharmaceutical according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023508084A
Other languages
English (en)
Japanese (ja)
Other versions
JP7882832B6 (ja
JP7882832B2 (ja
JP2023537369A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/044897 external-priority patent/WO2022032069A1/en
Publication of JP2023537369A publication Critical patent/JP2023537369A/ja
Publication of JP2023537369A5 publication Critical patent/JP2023537369A5/ja
Application granted granted Critical
Publication of JP7882832B2 publication Critical patent/JP7882832B2/ja
Publication of JP7882832B6 publication Critical patent/JP7882832B6/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023508084A 2020-08-06 2021-08-06 ベータコロナウイルス感染症に関連する疾患を治療または予防するための組成物及び方法 Active JP7882832B6 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063062138P 2020-08-06 2020-08-06
US63/062,138 2020-08-06
PCT/US2021/044897 WO2022032069A1 (en) 2020-08-06 2021-08-06 Compositions and methods for treating or preventing disease associated with beta coronavirus infection

Publications (4)

Publication Number Publication Date
JP2023537369A JP2023537369A (ja) 2023-08-31
JP2023537369A5 true JP2023537369A5 (cg-RX-API-DMAC7.html) 2024-08-14
JP7882832B2 JP7882832B2 (ja) 2026-06-30
JP7882832B6 JP7882832B6 (ja) 2026-07-31

Family

ID=80117684

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023508084A Active JP7882832B6 (ja) 2020-08-06 2021-08-06 ベータコロナウイルス感染症に関連する疾患を治療または予防するための組成物及び方法

Country Status (11)

Country Link
US (1) US20240033259A1 (cg-RX-API-DMAC7.html)
EP (1) EP4192457B1 (cg-RX-API-DMAC7.html)
JP (1) JP7882832B6 (cg-RX-API-DMAC7.html)
KR (1) KR20230048517A (cg-RX-API-DMAC7.html)
CN (1) CN116322662A (cg-RX-API-DMAC7.html)
AU (1) AU2021321535A1 (cg-RX-API-DMAC7.html)
CA (1) CA3188387A1 (cg-RX-API-DMAC7.html)
ES (1) ES3069166T3 (cg-RX-API-DMAC7.html)
IL (1) IL300406A (cg-RX-API-DMAC7.html)
MX (1) MX2023001570A (cg-RX-API-DMAC7.html)
WO (1) WO2022032069A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019046201A1 (en) 2017-08-30 2019-03-07 SEN-JAM Pharmaceutical LLC METHODS AND COMPOSITIONS FOR INHIBITING ADVERSE REACTIONS ASSOCIATED WITH VACCINATION
CN116178373B (zh) * 2022-12-06 2024-06-18 南方科技大学 非甾体抗炎药和gs-441524的二联体化合物及其制备方法与用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018232260A1 (en) * 2017-06-16 2018-12-20 SEN-JAM Pharmaceutical LLC Methods and compositions to inhibit symptoms associated with viral upper respiratory tract infections
WO2019046201A1 (en) * 2017-08-30 2019-03-07 SEN-JAM Pharmaceutical LLC METHODS AND COMPOSITIONS FOR INHIBITING ADVERSE REACTIONS ASSOCIATED WITH VACCINATION

Similar Documents

Publication Publication Date Title
JP2023522010A5 (cg-RX-API-DMAC7.html)
JP2024540183A5 (cg-RX-API-DMAC7.html)
JP2015526458A5 (cg-RX-API-DMAC7.html)
JP2025510368A5 (cg-RX-API-DMAC7.html)
JP2011500850A5 (cg-RX-API-DMAC7.html)
TWI455723B (zh) 納曲酮及安非他酮於治療超重或肥胖病患之用途
JP2023523557A5 (cg-RX-API-DMAC7.html)
JP2022532547A5 (cg-RX-API-DMAC7.html)
US20220387455A1 (en) Treatment of moderate to severe influenza
US20240115559A1 (en) Methods and Compositions to Inhibit Symptoms Associated with Viral Upper Respiratory Tract Infections
JP2024531799A5 (cg-RX-API-DMAC7.html)
CN116322662A (zh) 用于治疗或预防与β冠状病毒感染相关的疾病的组合物和方法
JP2023520929A5 (cg-RX-API-DMAC7.html)
JP7312286B2 (ja) うつ病を予防または治療するための安息香酸またはその塩および誘導体
Aizenberg et al. Sildenafil for selective serotonin reuptake inhibitor-induced erectile dysfunction in elderly male depressed patients
US20060173079A1 (en) Compositions and methods for improving the condition of patients suffering from copd and other diseases
JP2006508993A5 (cg-RX-API-DMAC7.html)
JP2025505294A5 (cg-RX-API-DMAC7.html)
JP2024541770A5 (cg-RX-API-DMAC7.html)
JP2024526880A5 (cg-RX-API-DMAC7.html)
JP2022538170A5 (cg-RX-API-DMAC7.html)
WO2007139232A1 (ja) インスリン感受性増強剤